FDA Draft Guidance Proposes Emergency-Use Authorization Policies
This article was originally published in The Gray Sheet
Executive Summary
Device and diagnostic firms should strive to contact FDA about emergency-use authorization for medical products before the agency officially declares an emergency, according to FDA draft guidelines
You may also be interested in...
Rule Change Frees Unapproved Tests To Play Bigger Role In Emergencies
FDA is amending its regulations to make it easier for a physician to test a patient for possible exposure to a terrorism-based or other infectious disease agent with an unapproved diagnostic without prior informed consent
Rule Change Frees Unapproved Tests To Play Bigger Role In Emergencies
FDA is amending its regulations to make it easier for a physician to test a patient for possible exposure to a terrorism-based or other infectious disease agent with an unapproved diagnostic without prior informed consent
AdvaMed Seeks Liability Protection For Emergency-Use Devices
AdvaMed is urging FDA to take steps to ensure that manufacturers of unapproved medical products authorized for use in a national emergency are protected from legal liability